Smooth	JJ
muscle	NN
alpha-actin	NN
expression	NN
and	CC
myofibroblast	NN
differentiation	NN
by	IN
TGFbeta	NN
are	VBP
dependent	JJ
upon	IN
MK2	NN
.	.

Fibroblasts	NNS
play	VBP
a	DT
major	JJ
role	NN
in	IN
processes	NNS
such	JJ
as	IN
wound	NN
repair	NN
,	,
scarring	NN
,	,
and	CC
fibrosis	NN
.	.

Differentiation	NN
into	IN
myofibroblasts	NNS
,	,
characterized	VBN
by	IN
upregulation	NN
of	IN
smooth	JJ
muscle	NN
alpha-actin	NN
(	(
smalpha	NN
)	)
in	IN
response	NN
to	TO
profibrotic	JJ
agents	NNS
such	JJ
as	IN
TGFbeta	NN
is	VBZ
believed	VBN
to	TO
be	VB
an	DT
important	JJ
step	NN
in	IN
fibrosis	NN
.	.

Therefore	RB
,	,
elucidating	VBG
mechanisms	NNS
of	IN
myofibroblast	NN
differentiation	NN
might	MD
reveal	VB
novel	JJ
targets	NNS
in	IN
treating	VBG
diseases	NNS
such	JJ
as	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

MK2	NN
is	VBZ
a	DT
kinase	NN
substrate	NN
of	IN
p38	NN
MAP	NN
kinase	NN
that	WDT
mediates	VBZ
some	DT
effects	NNS
of	IN
p38	NN
activation	NN
on	IN
the	DT
actin	NN
cytoskeleton	NN
.	.

Using	VBG
mouse	NN
embryonic	JJ
fibroblasts	NNS
(	(
MEF	NN
)	)
from	IN
MK2	NN
knockout	NN
(	(
MK2	NN
(	(
-	:
/	:
-	:
)	)
)	)
mice	NNS
,	,
we	PRP
demonstrate	VBP
that	IN
disrupting	VBG
expression	NN
of	IN
MK2	NN
expression	NN
reduces	VBZ
filamentous	JJ
actin	NN
and	CC
stress	NN
fibers	NNS
.	.

It	PRP
also	RB
causes	VBZ
MK2	NN
(	(
-	:
/	:
-	:
)	)
MEF	NN
to	TO
express	VB
less	JJR
smalpha	NN
than	IN
their	PRP$
corresponding	JJ
wild-type	JJ
(	(
WT	JJ
)	)
MEF	NN
at	IN
baseline	NN
and	CC
in	IN
response	NN
to	TO
TGFbeta	NN
.	.

Furthermore	RB
,	,
TGFbeta	NN
causes	VBZ
downregulation	NN
of	IN
smalpha	NN
in	IN
MK2	NN
(	(
-	:
/	:
-	:
)	)
MEF	NN
,	,
instead	RB
of	IN
upregulation	NN
observed	VBN
in	IN
WT	NNP
MEF	NNP
.	.

Expression	NN
of	IN
other	JJ
fibroblast	NN
markers	NNS
,	,
such	JJ
as	IN
collagen	NN
,	,
is	VBZ
not	RB
altered	VBN
in	IN
MK2	NN
(	(
-	:
/	:
-	:
)	)
MEF	NN
.	.

Our	PRP$
results	NNS
further	RB
suggest	VBP
that	IN
downregulation	NN
of	IN
smalpha	NN
in	IN
MK2	NN
(	(
-	:
/	:
-	:
)	)
MEF	NN
is	VBZ
not	RB
due	JJ
to	TO
lack	NN
of	IN
activation	NN
of	IN
serum	NN
responsive	JJ
promoter	NN
elements	NNS
,	,
but	CC
probably	RB
due	JJ
to	TO
reduced	VBN
smalpha	NN
message	NN
stability	NN
in	IN
these	DT
cells	NNS
.	.

These	DT
results	NNS
indicate	VBP
that	IN
MK2	NN
plays	VBZ
a	DT
key	JJ
role	NN
in	IN
regulation	NN
of	IN
smalpha	NN
expression	NN
,	,
and	CC
that	IN
targeting	VBG
MK2	NN
might	MD
present	VB
a	DT
therapeutic	JJ
approach	NN
in	IN
managing	NN
conditions	NNS
such	JJ
as	IN
pulmonary	JJ
fibrosis	NN
.	.

